Cargando…
Protocol for engineering E. coli Nissle 1917 to diagnose, record, and ameliorate inflammatory bowel disease in mice
Engineered microorganisms hold potential for disease diagnosis and treatment. Here, we present a protocol to engineer E. coli Nissle 1917 strain (iROBOT) using genome insertion and plasmid construction to diagnose, record, and ameliorate inflammatory bowel disease in mice. We describe steps for cons...
Autores principales: | Zou, Zhen-Ping, Fan, Yu-Hang, Du, Yue, Fang, Ting-Ting, Du, Wei, Zhou, Ying, Ye, Bang-Ce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154985/ https://www.ncbi.nlm.nih.gov/pubmed/37115666 http://dx.doi.org/10.1016/j.xpro.2023.102254 |
Ejemplares similares
-
The Administration of Escherichia coli Nissle 1917 Ameliorates Development of DSS-Induced Colitis in Mice
por: Rodríguez-Nogales, Alba, et al.
Publicado: (2018) -
Engineered E. coli Nissle 1917 for the reduction of vancomycin‐resistant Enterococcus in the intestinal tract
por: Geldart, Kathryn G., et al.
Publicado: (2018) -
Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut
por: Praveschotinunt, Pichet, et al.
Publicado: (2019) -
Engineered E. coli Nissle 1917 for delivery of bioactive IL-2 for cancer immunotherapy
por: Tumas, Sarunas, et al.
Publicado: (2023) -
Bioengineered Escherichia coli Nissle 1917 for tumour‐targeting therapy
por: Yu, Xiaoli, et al.
Publicado: (2019)